Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

About

What does TGTX do?
TG Therapeutics, based in Morrisville, North Carolina, develops treatments for B-cell malignancies and autoimmune diseases, with key candidates including Ublituximab, TG-1701, and TG-1801. The company employs 284 people and explores partnership opportunities for additional products.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New York, USA
Website
http://www.tgtherapeutics.com

Recently from Cashu

publisher logo
Cashu

TG Therapeutics (TGTX) Under Scrutiny After Director's Insider Share Sale

2 days ago

Key Stats

Market Cap
5.66B
Dividend Yield
0.00%
P/E Ratio
144.51
EPS
0.17
Revenue
329.00M
Avg. Volume
2.89M
Stocks
Health Care
tgtx
TG Therapeutics
TGTX
+0.86 (+2.45%)
36.025
USD
At close at Jun 20, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials